Cl1inical features and prognostic factors of patients with chordoma in the spine: A retrospective analysis of 153 patients in a single center

Neuro-Oncology

Volumn 17, Issue 5, 2015, Pages 725-732

  Meng, Tong ^a   Yin, Huabin ^a   Li, Bo ^a   Li, Zhenxi ^a   Xu, Wei ^a   Zhou, Wang ^a   Cheng, Mo ^a   Wang, Jing ^a   Zhou, Lei ^a   Yang, Xinghai ^a   Liu, Tielong ^a   Yan, Wangjun ^a   Song, Dianwen ^a   Xiao, Jianru ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

chordoma; prognostic factor; spine tumor; surgery; survival

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CHORDOMA; CHORDOMA IN THE SPINE; FEMALE; FOLLOW UP; FRANKEL GRADE; HUMAN; KARNOFSKY PERFORMANCE STATUS; LOCAL RECURRENCE FREE SURVIVAL; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREOPERATIVE PERIOD; RETROSPECTIVE STUDY; SPINE SURGERY; TOTAL EN BLOC SPONDYLECTOMY; VERY ELDERLY; DISEASE FREE SURVIVAL; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PROGNOSIS; SPINAL NEOPLASMS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHORDOMA; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SPINAL NEOPLASMS; YOUNG ADULT;

EID: 84928914686     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/nou331     Document Type: Article

References (39)

1. Healey JH, Lane JM. Chordoma: a critical review of diagnosis and treatment. Orthop Clin North Am. 1989;20(3):417-426.
2. McMaster ML, Goldstein AM, Bromley CM, et al. Chordoma: incidence and survival patterns in the United States, 1973-1995. Cancer Causes Control. 2001;12(1):1-11.
3. Casali PG, Stacchiotti S, Sangalli C, et al. Chordoma. Curr Opin Oncol. 2007;19(4):367-370.
4. Horten BC, Montague SR. In vitro characteristics of a sacrococcygeal chordoma maintained in tissue and organ culture systems. Acta Neuropathol. 1976;35(1):13-25.
5. Walcott BP, Nahed BV, Mohyeldin A, et al. Chordoma: current concepts, management, and future directions. Lancet Oncol. 2012;13(2):e69-e76.
6. Ferraresi V, Nuzzo C, Zoccali C, et al. Chordoma: clinical characteristics, management and prognosis of a case series of 25 patients. BMC Cancer. 2010;10:22.
7. Chambers PW, Schwinn CP. Chordoma. A clinicopathologic study of metastasis. Am J Clin Pathol. 1979;72(5):765-776.
8. Stacchiotti S, Casali PG, Lo Vullo S, et al. Chordoma of the mobile spine and sacrum: a retrospective analysis of a series of patients surgically treated at two referral centers. Ann Surg Oncol. 2010; 17(1):211-219.
9. Baratti D, Gronchi A, Pennacchioli E, et al. Chordoma: natural history and results in 28 patients treated at a single institution. Ann Surg Oncol. 2003;10(3):291-296.
10. Osaka S, Osaka E, Kojima T, et al. Long-term outcome following surgical treatment of sacral chordoma. J Surg Oncol. 2014; 109(3):184-188.
11. Bergh P, Kindblom LG, Gunterberg B, et al. Prognostic factors in chordoma of the sacrum and mobile spine: a study of 39 patients. Cancer. 2000;88(9):2122-2134.
12. Prabhakaran PS, Misra S, Kannan V, et al. Sacral chordomas: a 10-year study. Australas Radiol. 1998;42(1):42-46.
13. Wang Y, Xiao J, Wu Z, et al. Primary chordomas of the cervical spine: a consecutive series of 14 surgically managed cases. J Neurosurg Spine. 2012;17(4):292-299.
14. Wang Y, Xu W, Yang X, et al. Recurrent upper cervical chordomas after radiotherapy: surgical outcomes and surgical approach selection based on complications. Spine. 2013;38(18): E1141-E1148.
15. Frankel HL, Hancock DO, Hyslop G, et al. The value of postural reduction in the initial management of closed injuries of the spine with paraplegia and tetraplegia. I. Paraplegia. 1969;7(3): 179-192.
16. Chugh R, Tawbi H, Lucas DR, et al. Chordoma: the nonsarcoma primary bone tumor. Oncologist. 2007;12(11):1344-1350.
17. Tomita K, Kawahara N, Kobayashi T, et al. Surgical strategy for spinal metastases. Spine. 2001;26(3):298-306.
18. Enneking WF. A system of staging musculoskeletal neoplasms. Clin Orthop Relat Res. 1986;(204):9-24.
19. Boriani S, Weinstein JN, Biagini R. Primary bone tumors of the spine. Terminology and surgical staging. Spine. 1997;22(9): 1036-1044.
20. Tomita K, Kawahara N, Baba H, et al. Total en bloc spondylectomy. A new surgical technique for primary malignant vertebral tumors. Spine. 1997;22(3):324-333.
21. Boriani S, Biagini R, De Iure F, et al. En bloc resections of bone tumors of the thoracolumbar spine. A preliminary report on 29 patients. Spine. 1996;21(16):1927-1931.
22. Karnofsky DA. Clinical evaluation of anticancer drugs: cancer chemotherapy. Gann Monogr. 1967;2(2):223-231.
23. Xu W, Li X, Huang W, et al. Factors affecting prognosis of patients with giant cell tumors of the mobile spine: retrospective analysis of 102 patients in a single center. Ann Surg Oncol. 2013;20(3): 804-810.
24. Yin H, Zhou W, Meng J, et al. Prognostic factors of patients with spinal chondrosarcoma: a retrospective analysis of 98 consecutive patients in a single center. Ann Surg Oncol. 2014; 21(11):3572-3578.
25. Crnalic S, Hildingsson C, Wikstrom P, et al. Outcome after surgery for metastatic spinal cord compression in 54 patients with prostate cancer. Acta Orthop. 2012;83(1):80-86.
26. Ju DG, Zadnik PL, Groves ML, et al. Factors associated with improved outcomes following decompressive surgery for prostate cancer metastatic to the spine. Neurosurgery. 2013; 73(4):657-666.
27. Schwab JH, Healey JH, Rose P, et al. The surgical management of sacral chordomas. Spine. 2009;34(24):2700-2704.
28. Stener B, Gunterberg B. High amputation of the sacrum for extirpation of tumors. Principles and technique. Spine. 1978; 3(4):351-366.
29. Guppy KH, Chakrabarti I, Isaacs RS, et al. En bloc resection of a multilevel high-cervical chordoma involving C-2: new operative modalities: technical note. J Neurosurg Spine. 2013;19(2): 232-242.
30. Brown MJ, Kor DJ, Curry TB, et al. Sacral tumor resection: the effect of surgical staging on patient outcomes, resource management, and hospital cost. Spine. 2011;36(19):1570-1578.
31. Kim CH, Chung CK, Jahng TA, et al. Resumption of ambulatory status after surgery for nonambulatory patients with epidural spinal metastasis. Spine J. 2011;11(11):1015-1023.
32. Boriani S, Bandiera S, Donthineni R, et al. Morbidity of en bloc resections in the spine. Eur Spine J. 2010;19(2):231-241.
33. Bandiera S, Boriani S, Donthineni R, et al. Complications of en bloc resections in the spine. Orthop Clin North Am. 2009;40(1): 125-131, vii.
34. Ozkan E, Gupta S. Embolization of spinal tumors: vascular anatomy, indications, and technique. Tech Vasc Interv Radiol. 2011;14(3):129-140.
35. Vetter SC, Strecker EP, Ackermann LW, et al. Preoperative embolization of cervical spine tumors. Cardiovasc Intervent Radiol. 1997;20(5):343-347.
36. Boriani S, Chevalley F, Weinstein JN, et al. Chordoma of the spine above the sacrum. Treatment and outcome in 21 cases. Spine. 1996;21(13):1569-1577.
37. Austin-Seymour M, Munzenrider J, Linggood R, et al. Fractionated proton radiation therapy of cranial and intracranial tumors. Am J Clin Oncol. 1990;13(4):327-330.
38. Nishida Y, Kamada T, Imai R, et al. Clinical outcome of sacral chordoma with carbon ion radiotherapy compared with surgery. Int J Radiat Oncol Biol Phys. 2011;79(1):110-116.
39. McPherson CM, Suki D, McCutcheon IE, et al. Metastatic disease from spinal chordoma: a 10-year experssience. J Neurosurg Spine. 2006;5(4):277-280.